Actively Recruiting
A Randomized Trial of Dichoptic Treatment for Amblyopia in Children 4 to 7 Years of Age
Led by Jaeb Center for Health Research · Updated on 2026-02-11
238
Participants Needed
73
Research Sites
26 weeks
Total Duration
On this page
Sponsors
J
Jaeb Center for Health Research
Lead Sponsor
N
National Eye Institute (NEI)
Collaborating Sponsor
AI-Summary
What this Trial Is About
Researchers are studying children aged 4 to 7 years with amblyopia to compare two treatments watching dichoptic movies or shows using the Luminopia headset versus patching the fellow eye. The goal is to see if the Luminopia headset treatment used one hour per day, six days per week, is not worse than patching for two hours per day, seven days per week, in improving vision in the amblyopic eye over 26 weeks. This phase 3 randomized trial evaluates changes in distance visual acuity as the primary outcome. Participants will be randomly assigned to one of two groups. One group uses the Luminopia headset to watch dichoptic content for one hour daily which can be split into shorter sessions six days a week, wearing optical correction if needed. The other group uses an eye patch on the fellow eye for two hours daily also split into shorter sessions seven days a week, with optical correction as needed. After 26 weeks, those initially in the patching group who still have significant vision difference may be offered the Luminopia treatment and followed for an additional 26 weeks. Throughout the study, participants will undergo clinical assessments at 13 and 26 weeks, with follow-up visits at 39 and 52 weeks for those switching to Luminopia. Researchers will measure changes in distance visual acuity in the amblyopic eye, tracking treatment effects over time. Parents will maintain communication with the study team, and participants will continue using required spectacles or contact lenses. The total study duration varies up to 52 weeks depending on treatment response and group assignment.
CONDITIONS
Brief Title
Dichoptic Treatment for Amblyopia in Children 4 to 7 Years of Age
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age 4 to 7 years
- Amblyopic eye visual acuity between 20/40 and 20/200 inclusive
- Age-normal visual acuity in the fellow eye
- Interocular visual acuity difference of 3 or more logMAR lines
- Amblyopia caused by strabismus, anisometropia, or both
- No more than 2 weeks of prior dichoptic treatment
- No cycloplegic eyedrop treatment in the past 2 weeks
- Wearing required refractive correction based on recent cycloplegic refraction
- Willingness to wear the Luminopia headset
- Willingness to continue full-time spectacles or contact lens wear if needed
- Acceptance of random assignment to either treatment for 26 weeks
- Interpupillary distance between 52mm and 72mm
- Investigator agrees to prescribe treatment per protocol
- Parent understands protocol and accepts randomization
- Parent has phone access and agrees to contact
- No anticipated relocation outside study area within 52 weeks
You will not qualify if you...
- Heterotropia greater than 5 prism diopters at distance or near
- Need for prism lenses at enrollment
- Current bifocal spectacles (unless discontinued 2 weeks prior)
- Myopia worse than -6.00 diopters spherical equivalent in either eye
- Previous intraocular or refractive surgery
- Known skin reactions to patches or adhesives
- Ocular conditions reducing visual acuity (except nystagmus if vision criteria met)
- Diplopia occurring more than once per week in the last week
- History of light-induced seizures
- Severe developmental delay interfering with treatment or evaluation
- Prior participation in patching studies for amblyopia
- Immediate family member of study personnel or JAEB Center employees
Research Team
R
Raymond T Kraker, MSPH
B
Brooke P Fimbel
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here